Bayesian local exchangeability design for phase II basket trials

被引:6
作者
Liu, Yilin [1 ]
Kane, Michael [1 ]
Esserman, Denise [1 ]
Blaha, Ondrej [1 ]
Zelterman, Daniel [1 ]
Wei, Wei [1 ]
机构
[1] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT 06520 USA
基金
美国国家卫生研究院;
关键词
adaptive design; Bayesian analysis; clustering; master protocol; oncology; MULTIPLE TUMOR TYPES; STATISTICAL DESIGN; MASTER PROTOCOLS; CLINICAL-TRIALS; INHIBITION; BRAF;
D O I
10.1002/sim.9514
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We propose an information borrowing strategy for the design and monitoring of phase II basket trials based on the local multisource exchangeability assumption between baskets (disease types). In our proposed local-MEM framework, information borrowing is only allowed to occur locally, that is, among baskets with similar response rate and the amount of information borrowing is determined by the level of similarity in response rate, whereas baskets not considered similar are not allowed to share information. We construct a two-stage design for phase II basket trials using the proposed strategy. The proposed method is compared to competing Bayesian methods and Simon's two-stage design in a variety of simulation scenarios. We demonstrate the proposed method is able to maintain the family-wise type I error rate at a reasonable level and has desirable basket-wise power compared to Simon's two-stage design. In addition, our method is computationally efficient compared to existing Bayesian methods in that the posterior profiles of interest can be derived explicitly without the need for sampling algorithms. R scripts to implement the proposed method are available at .
引用
收藏
页码:4367 / 4384
页数:18
相关论文
共 30 条
  • [1] Adaptive Design for a Confirmatory Basket Trial in Multiple Tumor Types Based on a Putative Predictive Biomarker
    Beckman, R. A.
    Antonijevic, Z.
    Kalamegham, R.
    Chen, C.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (06) : 617 - 625
  • [2] Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trials
    Berry, Scott M.
    Broglio, Kristine R.
    Groshen, Susan
    Berry, Donald A.
    [J]. CLINICAL TRIALS, 2013, 10 (05) : 720 - 734
  • [3] Statistical Design and Considerations of a Phase 3 Basket Trial for Simultaneous Investigation of Multiple Tumor Types in One Study
    Chen, Cong
    Li, Xiaoyun
    Yuan, Shuai
    Antonijevic, Zoran
    Kalamegham, Rasika
    Beckman, Robert A.
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2016, 8 (03): : 248 - 257
  • [4] A Bayesian basket trial design using a calibrated Bayesian hierarchical model
    Chu, Yiyi
    Yuan, Ying
    [J]. CLINICAL TRIALS, 2018, 15 (02) : 149 - 158
  • [5] BLAST: Bayesian latent subgroup design for basket trials accounting for patient heterogeneity
    Chu, Yiyi
    Yuan, Ying
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 2018, 67 (03) : 723 - 740
  • [6] Dmitrienko Alex, 2009, Multiple testing problems in pharmaceutical statistics
  • [7] Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
    Flaherty, Keith T.
    Puzanov, Igor
    Kim, Kevin B.
    Ribas, Antoni
    McArthur, Grant A.
    Sosman, Jeffrey A.
    O'Dwyer, Peter J.
    Lee, Richard J.
    Grippo, Joseph F.
    Nolop, Keith
    Chapman, Paul B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (09) : 809 - 819
  • [8] Bayesian basket trial design with exchangeability monitoring
    Hobbs, Brian P.
    Landin, Rick
    [J]. STATISTICS IN MEDICINE, 2018, 37 (25) : 3557 - 3572
  • [9] Adaptive adjustment of the randomization ratio using historical control data
    Hobbs, Brian P.
    Carlin, Bradley P.
    Sargent, Daniel J.
    [J]. CLINICAL TRIALS, 2013, 10 (03) : 430 - 440
  • [10] Statistical design considerations for trials that study multiple indications
    Kaizer, Alexander M.
    Koopmeiners, Joseph S.
    Chen, Nan
    Hobbs, Brian P.
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2021, 30 (03) : 785 - 798